Display options
Cite
Kaloglu S, Guraslan H, Tekirdag AI, et al. Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer. Eurasian J Med. 2014;46(3):164-8doi: 10.5152/eajm.2014.47.
Kaloglu, S., Guraslan, H., Tekirdag, A. I., Dagdeviren, H., & Kaya, C. (2014). Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer. The Eurasian journal of medicine, 46(3), 164-8. https://doi.org/10.5152/eajm.2014.47
Kaloglu, Songul, et al. "Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer." The Eurasian journal of medicine vol. 46,3 (2014): 164-8. doi: https://doi.org/10.5152/eajm.2014.47
Kaloglu S, Guraslan H, Tekirdag AI, Dagdeviren H, Kaya C. Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer. Eurasian J Med. 2014 Oct;46(3):164-8. doi: 10.5152/eajm.2014.47. Epub 2014 Aug 26. PMID: 25610319; PMCID: PMC4299850.
Copy Download .nbib Format: NLM
Share it on

Eurasian J Med. 2014 Oct;46(3):164-8. doi: 10.5152/eajm.2014.47. Epub 2014 Aug 26.

Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer.

The Eurasian journal of medicine

Songul Kaloglu, Hakan Guraslan, Ali Ismet Tekirdag, Hediye Dagdeviren, Cihan Kaya

Affiliations

  1. Department of Obstetrics and Gynecology, Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey.
  2. Department of Obstetrics and Gynecology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

PMID: 25610319 PMCID: PMC4299850 DOI: 10.5152/eajm.2014.47

Abstract

OBJECTIVE: We aimed to evaluate the predictive value of preoperative thrombocytosis for postoperative tumor stage and tumor grade in patients with endometrial cancer.

MATERIALS AND METHODS: This was a retrospective study carried out in our gynecologic oncology department between January 2000 and December 2011. We reviewed the medical charts of 190 patients diagnosed with endometrial carcinoma and underwent complete staging procedure. The clinicopathologic characteristics of the patients such as; age, gravidity, parity, menopausal status, body mass index, co-morbidities (diabetes, hypertension etc.), stage, grade, histological subtype, depth of myometrial invasion, peritoneal washing cytology and preoperative platelet count were recorded. Endometrioid adenocarcinomas were graded according to the FIGO classification. Blood samples for the measurement of platelet count were obtained 3 days prior to the surgery. Thrombocytosis was defined as a platelet count of 300×10(9)/L. P values less than 0.05 derived from two-tailed tests were considered statistically significant.

RESULTS: The mean age of the study population was 55.4 (range 33-80) years. The mean gravidity was 3.8 (range 0-12) and the mean parity was 3.32 (range 0-11). 108 (56,8%) patients were with body mass index of >30 kg/m(2). The mean platelet count among women was 288, 6±90.7×10(9)/L (range 105-772×10(9)/L). The majority of the patients were with early stage diseases during the surgeries. 170 (89.5%) of the patients had stage I to II disease, and 20 (10.5%) of them had stage III to IV disease. There were no statistical significance between thrombocytosis and age, gravidity, parity, BMI, cancer grade and stage, histological subtype of the tumor, depth of invasion, cervical involvement, intrauterine tumor volume and peritoneal washing cytology.

CONCLUSION: We found that preoperative platelet count was not correlated with the stage or grade of endometrial cancer.

Keywords: Endometrial cancer; prognosis; thrombocytosis

References

  1. Int J Gynecol Cancer. 2009 Nov;19(8):1384-9 - PubMed
  2. Cancer. 1995 Sep 15;76(6):998-1005 - PubMed
  3. Exp Ther Med. 2013 May;5(5):1351-1354 - PubMed
  4. Int J Gynecol Cancer. 2001 May-Jun;11(3):236-40 - PubMed
  5. Arch Gynecol Obstet. 2009 Jan;279(1):53-6 - PubMed
  6. Semin Oncol. 1994 Apr;21(2 Suppl 3):3-8 - PubMed
  7. CA Cancer J Clin. 1990 Jan-Feb;40(1):9-26 - PubMed
  8. Tumour Biol. 2000 Sep-Oct;21(5):309-14 - PubMed
  9. Oncologist. 1998;3(2):II - PubMed
  10. Gynecol Oncol. 2004 Jan;92(1):211-4 - PubMed
  11. J Reprod Med. 2000 Nov;45(11):929-32 - PubMed
  12. Ann Oncol. 1996 Oct;7(8):843-8 - PubMed
  13. Gynecol Oncol. 1998 Aug;70(2):210-4 - PubMed
  14. Blood. 2001 Nov 1;98(9):2720-5 - PubMed
  15. Gynecol Oncol. 2000 Aug;78(2):137-42 - PubMed
  16. Gynecol Oncol. 1998 Oct;71(1):29-37 - PubMed
  17. J Cancer Res Clin Oncol. 2009 Jan;135(1):125-9 - PubMed
  18. Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):855-60 - PubMed
  19. Am J Gastroenterol. 1996 Jul;91(7):1417-22 - PubMed
  20. Gynecol Oncol. 2006 Dec;103(3):902-5 - PubMed

Publication Types